Conference - Berlin, Germany
Recent advances in technology allow us to consider the epigenome as well as the genome of a tumour on an individual level. These advances, in combination with high throughput technologies, are leading to rapid advances in the development of epigenetic biomarkers and novel therapeutic targets.
Who should attend?
This conference will cover some of the most recent advances and cutting edge research in the field of epigenetics and its relationship to cancer. We have created a programme that brings together basic scientists with translational and clinical researchers. During the meeting, there will be great opportunities for young scientists to meet the experts in the field, and we aim to create an open and engaging environment for discussion.
Topics to be covered include:
Epigenetic pathways
Epigenetics and senescence, aging and cancer
Epigenetics and genome stability
Epigenomics
Drugging the epigenome
Epigenetics and senescence, aging and cancer
Epigenetics and genome stability
Epigenomics
Drugging the epigenome
- Organization: European Association for Cancer research
Sun, Nov 08, 2015 - Wed, Nov 11, 2015
Harnack House - The Conference Centre of the Max Planck Society
Ihnestr. 16-20, 14195, Berlin, Germany
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.
